Health Canada Approves Drug to Slow Alzheimer’s Disease
On 25 October 2025, Health Canada approved lecanemab (brand name Leqembi) for use in Canada. This is the first medication in more than a decade—and the first in Canada with a mechanism of action targeting the underlying biology of Alzheimer’s disease. Lecanemab is indicated for people diagnosed with early-stage Alzheimer’s disease or mild cognitive impairment […]

Empowering Aspiring Writers: Overcoming Common Challenges and Embracing the Journey
Empowering Aspiring Writers: Tackling Challenges and Demystifying the Writing Process Starting a writing journey is exciting, yet it often feels intimidating. Many aspiring writers face challenges like self-doubt, procrastination, and perfectionism that can make the blank page seem overwhelming. But the good news is that these obstacles are entirely normal and manageable. By exploring key […]